Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus dosing algorithm in renal transplant recipients
2018-000011-25Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Aug 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), sponsored by Erasmus MC. Primary endpoint: Proportion of patients with tacrolimus C0 7.5–12.5 ng/mL on day 3. Started Aug 2018; status: active.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2018-000011-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000011-25.